Innovation in the cord blood industry takes many forms, including new business models. For this session, we will dive deep into the innovative model and sustainable structure, objectives and funding of the Arizona Public Cord Blood Program. 

Everyone agrees that cord blood donation is a vital component to growing and maintaining public stem cell registries worldwide, providing life-saving transplants for patients in need. However, public cord blood donation programs remain very rare at hospitals across the globe. Indeed, innovation is needed to maximize opportunities for public cord blood banking. New business models are needed to make these programs easier to establish and sustainable in the long term. 

Funded by the state lottery and bringing together a unique group of strategic partnerships, the Arizona Public Cord Blood Program represents one of the most innovative and sustainable business models in the industry. 

Join us to hear Kristen Wilt (Arizona Public Cord Blood Program) and Erin Eaton (Cord Blood Bank at MD Anderson Cancer Center) discuss:

• History and objectives of the Arizona Public Cord Blood Program
• Analysis of a diverse and sustainable state-run public donation program
• Keys to success: A unique business model & strategic partners

Go behind the scenes of this successful cord blood donation program and be inspired to launch a similar program in your hospital!

SHARE THE SCIENCE
with
​Kristen Wilt, MSN, RN
Cord Blood & Placenta Donation Coordinator
TMC HealthCare I Women’s & Children’s Services - Arizona Public Cord Blood Program
&
Erin Eaton
Program Manager of the Cord Blood Bank at MD Anderson Cancer Center
 
"An Innovative Model for Public Cord Blood Banking" 

Free webinar.  Open to the public.
​
Monday, July 31st 3pm US Eastern Time / 12pm US Pacific Time

REGISTER HERE

Cord blood is a vital source of stem cells for patients who need a stem cell transplant. Yet, some transplant centers hesitate using this medical resource due to lack of experience using cord blood. How can more medical teams become comfortable with using cord blood? Who will be the next generation of cord blood transplant specialists? Dr. Sachit Patel will answer these questions and more in his presentation: "Cord Blood: The Life BLOOD of the Heartland."

In this session, Dr. Patel will discuss how he has used training from early in his career to expand the utilization of cord blood transplants at the University of Nebraska Medical Center. He will showcase four separate patient-focused case studies. He will detail how he learned about cord blood transplants working alongside Dr. Joanne Kurztberg at Duke University and then took this experience to the University of Nebraska Medical Center where he led the state's 1st double cord blood transplant. 

Dr. Patel's presentation will highlight: 

- The importance of advancing cord blood awareness and utilization in more cancer centers

- Case studies from his experience of introducing cord blood treatments in his hospital

- The current state of industry around cord blood and what the future holds

SHARE THE SCIENCE
with
Dr. Sachit Patel
Associate Professor, Division of Hematology/Oncology Clinical Director,
Pediatric Blood and Marrow Transplantation at the University of Nebraska Medical Center
 
"Cord Blood: The Life BLOOD of the Heartland" 
Free webinar.  Open to the public.
​
Wednesday, June 21st 2pm US Eastern Time / 11am US Pacific Time

RECORDING NOW AVAILABLE. WATCH HERE.

If you are regular attendee of our Share the Science webinar series, then you already know that cord blood stem cells have numerous advantages over other stem cell sources. In particular, in comparison to bone marrow for example, cord blood is much easier to match to a patient in need of a stem cell transplant and cord blood units are available at a moment's notice given that the cord blood units only take a few days to ship once matched to a patient. Despite these advantages, Dr. Colleen Delaney and her team at Fred Hutch have observed a decline in the utilization of cord blood as a source of stem cells for allogeneic hematopoietic transplants. 

Where and why is this decline happening? There was an increase in the use of cord blood units in some regions of the world during COVID. Why has the trend reversed? How can we increase usage again? 

​Dr. Delaney will discuss her observations regarding this decline in the use of umbilical cord blood as a primary stem cell source for allogeneic hematopoietic transplants. She will discuss best practices for improving cord blood donor selection and increasing better quality and larger amounts of starting material products. This forward thinking session will address ways to potentially increase the use of cord blood units and highlight the pros/cons of its use. 

Key points of this webinar will include: 

• Reflecting on trends in cord blood usage
• Best practices in donor selection
• Increasing quality and quantities of collections
• Looking forward at ways to increase utilization